Your browser doesn't support javascript.
COVID-19 as a catalyst for reimagining cervical cancer prevention.
Luckett, Rebecca; Feldman, Sarah; Woo, Yin Ling; Moscicki, Anna-Barbara; Giuliano, Anna R; de Sanjosé, Silvia; Kaufmann, Andreas M; Leung, Shuk On Annie; Garcia, Francisco; Chan, Karen; Bhatla, Neerja; Stanley, Margaret; Brotherton, Julia; Palefsky, Joel; Garland, Suzanne.
  • Luckett R; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States.
  • Feldman S; Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
  • Woo YL; University of Malaya, Kuala Lumpur, Malaysia.
  • Moscicki AB; University of California, Los Angeles, Los Angeles, United States.
  • Giuliano AR; H Lee Moffitt Cancer Center and Research Institute, Tampa, United States.
  • de Sanjosé S; National Cancer Institute, Bethesda, United States.
  • Kaufmann AM; ISGlobal, Barcelona, Spain.
  • Leung SOA; Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Garcia F; Freie Universität Berlin, Berlin, Germany.
  • Chan K; Humboldt Universität zu Berlin, Berlin, Germany.
  • Bhatla N; McGill University Health Centre, Montreal, Canada.
  • Stanley M; Pima County, Tucson, United States.
  • Brotherton J; University of Hong Kong, Hong Kong, China.
  • Palefsky J; All India Institute of Medical Sciences, New Delhi, India.
  • Garland S; University of Cambridge, Cambridge, United Kingdom.
Elife ; 122023 04 18.
Artículo en Inglés | MEDLINE | ID: covidwho-2316753
ABSTRACT
Cervical cancer has killed millions of women over the past decade. In 2019 the World Health Organization launched the Cervical Cancer Elimination Strategy, which included ambitious targets for vaccination, screening, and treatment. The COVID-19 pandemic disrupted progress on the strategy, but lessons learned during the pandemic - especially in vaccination, self-administered testing, and coordinated mobilization on a global scale - may help with efforts to achieve its targets. However, we must also learn from the failure of the COVID-19 response to include adequate representation of global voices. Efforts to eliminate cervical cancer will only succeed if those countries most affected are involved from the very start of planning. In this article we summarize innovations and highlight missed opportunities in the COVID response, and make recommendations to leverage the COVID experience to accelerate the elimination of cervical cancer globally.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Infecciones por Papillomavirus / COVID-19 Tipo de estudio: Estudios diagnósticos Tópicos: Vacunas Límite: Femenino / Humanos Idioma: Inglés Año: 2023 Tipo del documento: Artículo País de afiliación: ELife.86266

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Infecciones por Papillomavirus / COVID-19 Tipo de estudio: Estudios diagnósticos Tópicos: Vacunas Límite: Femenino / Humanos Idioma: Inglés Año: 2023 Tipo del documento: Artículo País de afiliación: ELife.86266